Nippon India Pharma Fund Direct G
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct G
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 9166.4
Nippon India Pharma Fund Direct G - Nav Details
Nav Date
: 13-Oct-2026
NAV [Rs.]
: 611.7552
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct G- NAV Chart
Nippon India Pharma Fund Direct G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -2.54 | -4.16 | -2.95 | 9.82 | 6.83 | 16.76 | 12.77 | 17.04 |
| Category Avg | -2.13 | -4.82 | -1.26 | 15.33 | 11.15 | 19.52 | 13.42 | 14.64 |
| Category Best | -0.75 | -2.75 | 2.02 | 23.88 | 22.47 | 28.86 | 17.28 | 28.76 |
| Category Worst | -2.57 | -7.6 | -4.87 | 4.65 | -1.81 | 14.32 | 10.07 | -7.7 |
Nippon India Pharma Fund Direct G- Latest Dividends
No Records Found
Nippon India Pharma Fund Direct G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 11.71 | 5906349 | 1,072.94 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 7.10 | 700754 | 651.10 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.17 | 2783991 | 565.20 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.01 | 4095054 | 551.19 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.45 | 4049746 | 499.33 |
| Equity | Apollo Hospitals | Healthcare Services | 4.89 | 548795 | 448.11 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 4.38 | 1603562 | 401.49 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 3.92 | 2355745 | 359.13 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.61 | 913918 | 330.91 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 3.11 | 1029460 | 285.08 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.87 | 1364742 | 262.98 |
| Equity | Max Healthcare | Healthcare Services | 2.70 | 2658082 | 247.14 |
| Equity | Vijaya Diagnost. | Healthcare Services | 2.62 | 1671618 | 240.32 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.53 | 800549 | 232.11 |
| Equity | Medplus Health | Retailing | 2.53 | 3545229 | 232.17 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.32 | 78546 | 213.05 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.24 | 3837967 | 205.00 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 2.24 | 9937272 | 205.22 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.17 | 1000578 | 198.81 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.82 | 323678 | 167.13 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 1.65 | 902630 | 150.91 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.61 | 823911 | 147.59 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.51 | 3896349 | 138.47 |
| Equity | Syngene Intl. | Healthcare Services | 1.40 | 3501497 | 127.90 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.36 | 640910 | 124.52 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.35 | 318249 | 123.33 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 1.21 | 1351672 | 110.63 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 1.19 | 1275040 | 109.47 |
| Equity | Fortis Health. | Healthcare Services | 1.13 | 1346128 | 103.65 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.01 | 2504071 | 92.72 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.00 | 300272 | 91.79 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 0.89 | 213659 | 81.25 |
| Equity | Molbio Diagnosti | Healthcare Equipment & Supplies | 0.54 | 380293 | 49.77 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.48 | 1680015 | 43.96 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.42 | 62568 | 38.70 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.17 | 111738 | 15.34 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
8,03,520.11
Trustee/s:
NA
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
NA
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
